Q2 2012
Released Aug 14, 2012, after the close
10-Q filed Aug 14, 2012, 45 days after period end · 0001144204-12-045753
Q2 2012 · 10-Q
Revenue$302.00K$302.00K −52.6% vs Q2 2011−43.3% vs Q1 2012
Net Income-$754.00K-$754.00K N/M vs Q2 2011N/M vs Q1 2012
EPS Diluted-$0.07-$0.07 N/M vs Q2 2011N/M vs Q1 2012
Gross Profit$267,000+31.5%
Operating Income-$812,000N/M
Operating Cash Flowderived-$797,000N/M
Margins · derived
Gross margin88.4%+56.5 pt vs Q2 2011
Operating margin-268.9%−175.0 pt vs Q2 2011
Net margin-249.7%−155.2 pt vs Q2 2011
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $302.00K | $637.00K | — |
| Net Income | -$754.00K | -$602.00K | -$365.00K |
| EPS Diluted | -$0.07 | -$0.06 | -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR